Artificial Intelligence from ScreenPoint Medical and Volpara

Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands

Related Keywords

New Zealand , Nijmegen , Gelderland , Netherlands , California , United States , San Francisco , Wellington , New Zealand General , Ralph Highnam , Gewinn Nur , Nico Karssemeijer , Volpara Trudensity , Radboud University , University Of California , Volpara Health , Mayo Clinic , Exam Score , Artificial Intelligence System , Volumetric Density , Risk Prediction , Advanced Breast Cancer , Low Risk , Professor Nico Karssemeijer , Chief Scientific Officer , Screenpoint Medical , Chief Science , Innovation Officer , Point Medical , Artificial , Intelligence , Rom , Screenpoint , Medical , Volpara , Health , Emonstrates , Ability , Redict , Song , Term , Breast , Dancer , Risk ,